Alexion Nears $25M Settlement With SEC To End FCPA Probe
Alexion Pharmaceuticals Inc. has reached a preliminary agreement under which it would pay less than $25 million to end the U.S. Securities and Exchange Commission's investigation into possible violations of the...To view the full article, register now.
Already a subscriber? Click here to view full article